|
Name |
Cajanol
|
Molecular Formula | C17H16O6 | |
IUPAC Name* |
5-hydroxy-3-(4-hydroxy-2-methoxyphenyl)-7-methoxy-2,3-dihydrochromen-4-one
|
|
SMILES |
COC1=CC(=C2C(=C1)OCC(C2=O)C3=C(C=C(C=C3)O)OC)O
|
|
InChI |
InChI=1S/C17H16O6/c1-21-10-6-13(19)16-15(7-10)23-8-12(17(16)20)11-4-3-9(18)5-14(11)22-2/h3-7,12,18-19H,8H2,1-2H3
|
|
InChIKey |
RYYWWFXWFMYKJM-UHFFFAOYSA-N
|
|
Synonyms |
Cajanol; 61020-70-0; U192S21MNA; UNII-U192S21MNA; SCHEMBL571648; DTXSID00976519; LMPK12050499; 5-hydroxy-3-(4-hydroxy-2-methoxyphenyl)-7-methoxy-2,3-dihydrochromen-4-one; 2,3-DIHYDRO-5-HYDROXY-3-(4-HYDROXY-2-METHOXYPHENYL)-7-METHOXY-4H-1-BENZOPYRAN-4-ONE; XC161666; 4',5-Dihydroxy-2',7-dimethoxyisoflavanone; 5-hydroxy-3-(4-hydroxy-2-methoxyphenyl)-7 -methoxychroman-4-one; 5-Hydroxy-3-(4-hydroxy-2-methoxyphenyl)-7-methoxy-2,3-dihydro-4H-1-benzopyran-4-one; 4H-1-BENZOPYRAN-4-ONE, 2,3-DIHYDRO-5-HYDROXY-3-(4-HYDROXY-2-METHOXYPHENYL)-7-METHOXY-
|
|
CAS | 61020-70-0 | |
PubChem CID | 442670 | |
ChEMBL ID | CHEMBL1689287 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 316.3 | ALogp: | 2.9 |
HBD: | 2 | HBA: | 6 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 85.2 | Aromatic Rings: | 3 |
Heavy Atoms: | 23 | QED Weighted: | 0.904 |
Caco-2 Permeability: | -4.812 | MDCK Permeability: | 0.00001850 |
Pgp-inhibitor: | 0.007 | Pgp-substrate: | 0.05 |
Human Intestinal Absorption (HIA): | 0.009 | 20% Bioavailability (F20%): | 0.01 |
30% Bioavailability (F30%): | 0.047 |
Blood-Brain-Barrier Penetration (BBB): | 0.038 | Plasma Protein Binding (PPB): | 98.58% |
Volume Distribution (VD): | 0.571 | Fu: | 2.38% |
CYP1A2-inhibitor: | 0.962 | CYP1A2-substrate: | 0.942 |
CYP2C19-inhibitor: | 0.797 | CYP2C19-substrate: | 0.489 |
CYP2C9-inhibitor: | 0.743 | CYP2C9-substrate: | 0.951 |
CYP2D6-inhibitor: | 0.753 | CYP2D6-substrate: | 0.92 |
CYP3A4-inhibitor: | 0.888 | CYP3A4-substrate: | 0.495 |
Clearance (CL): | 11.115 | Half-life (T1/2): | 0.392 |
hERG Blockers: | 0.07 | Human Hepatotoxicity (H-HT): | 0.164 |
Drug-inuced Liver Injury (DILI): | 0.663 | AMES Toxicity: | 0.204 |
Rat Oral Acute Toxicity: | 0.408 | Maximum Recommended Daily Dose: | 0.717 |
Skin Sensitization: | 0.593 | Carcinogencity: | 0.162 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.408 |
Respiratory Toxicity: | 0.384 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000700 | 0.437 | D07MGA | 0.437 | ||||
ENC002461 | 0.430 | D06GCK | 0.371 | ||||
ENC001772 | 0.430 | D0F7CS | 0.339 | ||||
ENC000938 | 0.409 | D0L1JW | 0.333 | ||||
ENC002134 | 0.409 | D0AZ8C | 0.317 | ||||
ENC001631 | 0.409 | D0D4HN | 0.307 | ||||
ENC003661 | 0.402 | D0W8WB | 0.305 | ||||
ENC006013 | 0.402 | D0I9HF | 0.300 | ||||
ENC002517 | 0.402 | D02LZB | 0.299 | ||||
ENC001770 | 0.386 | D04TDQ | 0.296 |